I never claimed it was M&G, I was just pointing out that their new product showed some SIMILAR benefit.
This is relevant, as plate based assays were discussed at the AGM, and in the latest quarterly.
"Work has commenced on the second product opportunity under the Affymetrix Agreement. The initial data on microtitre plates is sufficiently promising for us to share it with our Affymetrix partners to assist in further scoping out the project"
interesting new product from ebio, page-6
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $20.83K | 964.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2247357 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 164375 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |